[HTML][HTML] The Diagnostic Role of 18F-Choline, 18F-Fluciclovine and 18F-PSMA PET/CT in the Detection of Prostate Cancer With Biochemical Recurrence: A Meta …

R Wang, G Shen, M Huang, R Tian - Frontiers in Oncology, 2021 - frontiersin.org
Background Diagnosing the biochemical recurrence (BCR) of prostate cancer (PCa) is a
clinical challenge, and early detection of BCR can help patients receive optimal treatment …

Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial

WP Fendler, J Calais, M Eiber, RR Flavell… - JAMA …, 2019 - jamanetwork.com
Importance In retrospective studies, 68 Ga-PSMA-11 positron emission tomographic (PET)
imaging improves detection of biochemically recurrent prostate cancer compared with …

18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm …

J Calais, F Ceci, M Eiber, TA Hope, MS Hofman… - The Lancet …, 2019 - thelancet.com
Summary Background National Comprehensive Cancer Network guidelines consider 18 F-
fluciclovine PET-CT for prostate cancer biochemical recurrence localisation after radical …

The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial

GL Andriole, L Kostakoglu, A Chau, F Duan… - The Journal of …, 2019 - auajournals.org
Purpose: The prospective, multicenter LOCATE (18F Fluciclovine [FACBC] PET/CT in
Patients with Rising PSA after Initial Prostate Cancer Treatment) trial assessed the impact of …

[HTML][HTML] 18F-Fluciclovine PET/CT performance in biochemical recurrence of prostate cancer: a systematic review

S Rais-Bahrami, JA Efstathiou, CM Turnbull… - Prostate Cancer and …, 2021 - nature.com
Background A systematic literature review of the performance of 18Fluorine-fluciclovine
PET/CT for imaging of men with recurrent prostate cancer was performed. Methods Scientific …

A prospective head-to-head comparison of 18F-fluciclovine with 68Ga-PSMA-11 in biochemical recurrence of prostate cancer in PET/CT

B Pernthaler, R Kulnik, C Gstettner… - Clinical nuclear …, 2019 - journals.lww.com
Purpose One of the major challenges for all imaging modalities is accurate detection of
prostate cancer (PCa) recurrence. Beyond the established 68 Ga-PSMA, a novel promising …

[HTML][HTML] Effect of 18F-fluciclovine positron emission tomography on the management of patients with recurrence of prostate cancer: results from the FALCON trial

AF Scarsbrook, D Bottomley, EJ Teoh… - International Journal of …, 2020 - Elsevier
Purpose Early and accurate localization of lesions in patients with biochemical recurrence
(BCR) of prostate cancer may guide salvage therapy decisions. The present study, 18 F …

18F-fluciclovine PET/CT detection of recurrent prostate carcinoma in patients with serum PSA≤ 1 ng/mL after definitive primary treatment

JR England, J Paluch, LK Ballas… - Clinical nuclear …, 2019 - journals.lww.com
Purpose The aims of this study were to report on our initial experience using 18 F-
fluciclovine PET/CT to detect recurrent prostate carcinoma in patients with low serum …

Bayesian penalised likelihood reconstruction (Q.Clear) of 18F-fluciclovine PET for imaging of recurrent prostate cancer: semi-quantitative and clinical evaluation

EJ Teoh, DR McGowan, DM Schuster… - The British journal of …, 2018 - academic.oup.com
Objective: 18F-Fluciclovine (FACBC) is an amino acid PET radiotracer approved for
recurrent prostate cancer imaging. We investigate the use of Bayesian penalised likelihood …

Validating modern NRG Oncology pelvic nodal and Groupe Francophone de Radiothérapie Urologique prostate bed contouring guidelines for post-prostatectomy …

G Harmon, D Chan, B Lee, C Miller, A Gorbonos… - International Journal of …, 2021 - Elsevier
Purpose We used the patterns of recurrence on 18 F-fluciclovine positron emission
tomography (PET)–computed tomography (CT) in patients enrolled in the LOCATE trial after …